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LETTERCould Pathophysiology
Failure Be Ruled Out?To the Editor:
I read with great interest the article by von Arx et al1
published in the The American Journal of Medicine. Arx
et al presented a case showing that renal denervation did not
lower blood pressure in a drug-naïve patient and provided
evidence that the nonresponsiveness of blood pressure to
renal denervation may be due to arterial stiffness.
One of the possible reasons for the nonresponsiveness of
blood pressure to renal denervation is pathophysiology
failure. Pathophysiology failure means that renal sympa-
thetic activity does not increase in a hypertensive patient.
Arx et al1 stated that they ruled out this possibility because
systolic blood pressure variability of this patient was
decreased from 18.0 mm Hg at baseline to 12.6 mm Hg at
3 months after renal denervation. The decrease in systolic
blood pressure variability may indicate that the renal
denervation procedure was successful in this patient; how-
ever, it did not provide information on whether the base-
line blood pressure variability was elevated compared with
that in the age-matched normotensive population. Therefore,
it is still possible that renal sympathetic activity did not
increase in this patient and that pathophysiology failureFunding: This work is funded by a grant from the National Health and
Medical Research Council (1062671). The funding body played no role in
the production of this publication.
Conﬂict of Interest: None.
Authorship: The author had access to the data and played a role in
writing this manuscript.
0002-9343/$ -see front matter  2014 Elsevier Inc. All rights reserved.may, in part, contribute to the nonresponsiveness of blood
pressure to renal denervation in this patient.
Systolic blood pressure variability, as von Arx et al1
pointed out, has been reported to be correlated with mus-
cle sympathetic nerve activity.2 However, this correlation
was observed in young normotensive subjects with a mean
age of 31 years.2 This young age is different from the mean
age of patients undergoing renal denervation, which is
approximately 60 years.3,4 Therefore, the usefulness of
systolic blood pressure variability as a proxy of sympathetic
activity in the elderly population is still to be established.
Therefore, it is possible that pathophysiology failure
may, in part, contribute to the nonresponsiveness of blood
pressure to renal denervation in this patient.
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